Panozin (Paricalcitol)

Paricalcitol, the active ingredient in Panozin, is a vitamin D analog presented as a 0 mg oral tablet for oral use. It is used to manage secondary hyperparathyroidism in patients with chronic kidney disease on dialysis. GNH USA supplies Panozin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Panozin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Paricalcitol is employed in the management of disorders that involve dysregulated parathyroid hormone activity.

- Secondary hyperparathyroidism: Reduces serum parathyroid hormone levels in dialysis‑dependent chronic kidney disease patients. - Hypercalcemia prevention: Helps mitigate calcium elevation associated with secondary hyperparathyroidism treatment. - Vitamin D deficiency deficiency : Supports the regulation of calcium‑phosphate metabolism when standard vitamin D therapy is insufficient. - C   

The